Newer Diabetes Drugs, Including GLP-1 Agonists, Tied to Autoimmunity Risk

(MedPage Today) — Analysis of hundreds of thousands of patient records showed differing risks for autoimmune disorders for new users of the more recent types of antidiabetic medications.
Rates of new-onset autoimmune conditions were compared…

Recent Posts

editors picks

Top Reviews